PAUL J. CLANCY - Corporate Board Profile

INCYTE CORP

Filing Date	Source Excerpt
2017-04-17	Paul J. Clancy has more than 30 years of experience in financial management and strategic business planning, and has served as the Executive Vice President, Finance and Chief Financial Officer of Biogen Inc. (formerly known as Biogen Idec Inc.), a biotechnology company, since August 2007. He also served as Senior Vice President of Finance of Biogen, with responsibilities for leading the treasury, tax, investor relations and business planning groups. Prior to the 2003 merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation to form Biogen, Mr. Clancy was the Vice President of Portfolio Management of Biogen. He joined Biogen in 2001 as Vice President of U.S. Marketing. Before Biogen, Mr. Clancy spent 13 years at PepsiCo Inc., a food and beverage company, serving in a variety of financial and general management positions, including Vice President and General Manager of their Great West Business Unit. Mr. Clancy is also a director of Agios Pharmaceuticals, Inc.
2018-03-14	Paul J. Clancy Executive Vice President and Chief Financial Officer Alexion Pharmaceuticals, Inc. Director since 2015 Age 56 Independent Director Committees Audit (Chair) Mr. Clancy has more than 30 years of experience in financial management and strategic business planning.
2019-03-21	Mr. Clancy has more than 30 years of experience in financial management and strategic business planning, and has served as the Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc., a biopharmaceutical company, since July 2017.
2020-04-20	Paul J. Clancy INDEPENDENT DIRECTOR Age: 58 COMMITTEES: Audit and Finance (Chair) DIRECTOR SINCE: 2015 Mr. Clancy has more than 30 years of experience in financial management and strategic business planning.
2021-04-16	Mr. Clancy has more than 30 years of experience in financial management and strategic business planning, and served as a senior advisor from October 2019 until July 2020 to, and as the Executive Vice President and Chief Financial Officer from July 2017 through October 2019 of, Alexion Pharmaceuticals, Inc., a biopharmaceutical company.
2022-04-29	Mr. Clancy has more than 30 years of experience in financial management and strategic business planning, and served as a senior advisor from October 2019 until July 2020 to, and as the Executive Vice President and Chief Financial Officer from July 2017 through October 2019 of, Alexion Pharmaceuticals, Inc., a biopharmaceutical company. Prior to joining Alexion, Mr. Clancy served as Executive Vice President, Finance and Chief Financial Officer of Biogen Inc. (formerly known as Biogen Idec Inc.), a biopharmaceutical company, from August 2007 until June 2017. He also served as Senior Vice President of Finance of Biogen, with responsibilities for leading the treasury, tax, investor relations and business planning groups. Prior to the 2003 merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation to form Biogen, Mr. Clancy was the Vice President of Portfolio Management of Biogen. He joined Biogen in 2001 as Vice President of U.S. Marketing. Before Biogen, Mr. Clancy spent 13 years at PepsiCo Inc., a food and beverage company, serving in a variety of financial, strategy and general management positions. The Board has concluded that Paul J. Clancy should serve on the Board because he has significant financial and executive leadership experience at large multi-national biopharmaceutical companies. Mr. Clancy also has experience as a director of a publicly held biotechnology company, and his breadth and depth of financial experience position him well to serve as Chair of the Audit and Finance Committee of the Board. Other Public Company Boards: Current Agios Pharmaceuticals, Inc. Exact Sciences Corporation Xilio Therapeutics, Inc. Past 5 Years None
2023-04-28	Paul J. Clancy, Independent Director, Former Executive Vice President and Chief Financial Officer, Alexion Pharmaceuticals, Inc., Age: 61, Director Since: 2015, Committees: Audit and Finance (Chair), Compensation, 2022 Director Compensation Table: Total $462,468
2024-04-29	Paul J. Clancy INDEPENDENT DIRECTOR Age: 62 COMMITTEES: Audit and Finance (Chair), Compensation DIRECTOR SINCE: 2015